Evaluación del deseo sexual inhibido en pacientes que reciben quimioterapia. Solca Cuenca 2020

Abstract

BACKGROUND: Cancer is a highly prevalent disease, which affects several spheres of the human being, sexuality is not an exception. However, it is considered to be the area least addressed in the management of cancer patients. GENERAL OBJECTIVE: To evaluate inhibited sexual desire in patients receiving chemotherapy at the SOLCA Cuenca 2020. METHODOLOGY: A descriptive study was carried out in cancer patients who received chemotherapy at the SOLCA Cuenca during the months of September, October and November in 2020. For this methodology, a form was given to the cancer patients that evaluate inhibited sexual desire. The tabulation and analysis of variables was performed using the SPSS version 20.00 program, percentages and frequencies were used as statistical measures. RESULTS: The frequency of inhibited sexual desire in the study population was 51.4%, a 69.01% of patients with inhibited sexual desire also presented aggravations and 77.5% experienced consequences. The frequency of the population in this study that did not receive medical counseling on sexuality was 83.3%. On the other hand, the frequency of the population that would like to receive medical counseling was 74.6%. CONCLUSION: To conclude, approximately half of the patients who were surveyed, presented a decrease in their sexual desire, and only 17% received counseling on the subject. This shows us that, despite being a fairly common problem, it is little addressed during oncological treatment.